Electrocore Inc.

Electrocore Inc. is a medical technology company specializing in non-invasive neuromodulation therapies, particularly targeting the vagus nerve for a range of neurological and metabolic conditions. Its core focus is on developing and commercializing non-invasive vagus nerve stimulation (nVNS) devices designed to address disorders such as migraine, cluster headache, and symptoms related to mild traumatic brain injuries. Notably, Electrocore has expanded its technological portfolio with the acquisition of NeuroMetrix, enhancing its capabilities in non-invasive bioelectronic medicine. The company's flagship products, including gammaCore, demonstrate its commitment to innovative, drug-free approaches for conditions traditionally managed with pharmaceuticals. Electrocore Inc. occupies a significant position within the broader medical device sector, addressing a growing market demand for alternative and adjunctive therapies that blend digital health and clinical treatment. Its solutions impact both patient quality of life and the evolving landscape of neurology and pain management therapies.